You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 13, 2026

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
Jody Groenendyk1, Monika Dabrowska, Marek Michalak
1Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Mutations in calnexin, an endoplasmic reticulum chaperone, impaired its ability to prevent protein aggregation. Specific mutations also altered binding to the folding enzyme ERp57, impacting calnexin
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: